Histone lysine demethylase inhibition is a disease-modifying therapy for hypertrophic cardiomyopathy
- DOI
- 10.64898/2026.08.07.743611
- Published
- 2026-08-13
- Container
- Not recorded
- Publisher
- openRxiv
- Open access
- unknown
Credibility signals
uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.64898/2026.08.07.743611,
title = {Histone lysine demethylase inhibition is a disease-modifying therapy for hypertrophic cardiomyopathy},
author = {Manjeet Singh and Yan Fan and Damir Alzhanov and Lingling Duan and Tram Anh Tran and Dinesh Ravindra Raju and Jinhua Wen and Christian Lopez Escobar and Matthias Peltz and Pietro Bajona and Xing Chao and Jun Liao and Dian J. Cao and Eric N Olson and Elisabeth D Martinez and Zhi-Ping Liu},
year = {2026},
doi = {10.64898/2026.08.07.743611},
url = {https://doi.org/10.64898/2026.08.07.743611}
}RIS
TY - JOUR TI - Histone lysine demethylase inhibition is a disease-modifying therapy for hypertrophic cardiomyopathy AU - Manjeet Singh AU - Yan Fan AU - Damir Alzhanov AU - Lingling Duan AU - Tram Anh Tran AU - Dinesh Ravindra Raju AU - Jinhua Wen AU - Christian Lopez Escobar AU - Matthias Peltz AU - Pietro Bajona AU - Xing Chao AU - Jun Liao AU - Dian J. Cao AU - Eric N Olson AU - Elisabeth D Martinez AU - Zhi-Ping Liu PY - 2026 DO - 10.64898/2026.08.07.743611 UR - https://doi.org/10.64898/2026.08.07.743611 ER -
APA
Singh, M., Fan, Y., Alzhanov, D., Duan, L., Tran, T. A., Raju, D. R., Wen, J., Escobar, C. L., Peltz, M., Bajona, P., Chao, X., Liao, J., Cao, D. J., Olson, E. N., Martinez, E. D., & Liu, Z. (2026). Histone lysine demethylase inhibition is a disease-modifying therapy for hypertrophic cardiomyopathy. https://doi.org/10.64898/2026.08.07.743611
Source records
- crossref · retrieved 2026-11-08T21:20:34.188Z